Literature DB >> 7797026

Eicosanoids and the gastrointestinal tract.

C E Eberhart1, R N Dubois.   

Abstract

Determining the role of eicosanoids in gastrointestinal physiology and pathophysiology has been an active area of investigation over the past 20 years. The landmark discovery of prostaglandin endoperoxide synthase and other enzymes involved in the production of arachidonic acid products (lipoxygenases and epoxygenases) ushered in a new era of research. The goal of this review is to distill a large body of work pertaining to studies of eicosanoids in the gastrointestinal tract. This review has been organized according both to functional (secretion and motility) and disease-related (inflammation, mucosal injury, and neoplasia) effects. The aim of this article is to present a clear summary of this area of gastroenterology so that future research can be directed in a logical and productive manner.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7797026     DOI: 10.1016/0016-5085(95)90296-1

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  69 in total

1.  Cytotoxic necrotizing factor from Escherichia coli induces RhoA-dependent expression of the cyclooxygenase-2 Gene.

Authors:  W Thomas; Z K Ascott; D Harmey; L W Slice; E Rozengurt; A J Lax
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.441

Review 2.  A lay doctor's guide to the inflammatory process in the gastrointestinal tract.

Authors:  S Pathmakanthan; C J Hawkey
Journal:  Postgrad Med J       Date:  2000-10       Impact factor: 2.401

3.  Prostaglandins I2 and E2 have a synergistic role in rescuing epithelial barrier function in porcine ileum.

Authors:  A T Blikslager; M C Roberts; J M Rhoads; R A Argenzio
Journal:  J Clin Invest       Date:  1997-10-15       Impact factor: 14.808

Review 4.  Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward.

Authors:  David G Menter; Richard L Schilsky; Raymond N DuBois
Journal:  Clin Cancer Res       Date:  2010-02-23       Impact factor: 12.531

5.  Synergistic action of famotidine and chlorpheniramine on acetic acid-induced chronic gastric ulcer in rats.

Authors:  Zhen Qin; Chao Chen
Journal:  World J Gastroenterol       Date:  2005-12-07       Impact factor: 5.742

Review 6.  Do non-steroidal anti-inflammatory drugs cause exacerbations of inflammatory bowel disease?

Authors:  Linda A Feagins; Byron L Cryer
Journal:  Dig Dis Sci       Date:  2010-02       Impact factor: 3.199

7.  Pranlukast, a leukotriene receptor antagonist, prolongs the duration of the migrating motor complex in dogs.

Authors:  Moises Garcia; Toshihiro Nakabayashi; Erito Mochiki; Norihiro Haga; Ivan Pacheco; Tomoaki Suzuki; Hiroyuki Kuwano
Journal:  Dig Dis Sci       Date:  2004-08       Impact factor: 3.199

8.  Marked elevations in pro-inflammatory polyunsaturated fatty acid metabolites in females with irritable bowel syndrome.

Authors:  Gerard Clarke; Peter Fitzgerald; Alan A Hennessy; Eugene M Cassidy; Eamonn M M Quigley; Paul Ross; Catherine Stanton; John F Cryan; Timothy G Dinan
Journal:  J Lipid Res       Date:  2009-11-11       Impact factor: 5.922

9.  Downregulation of prostaglandin E receptor subtype EP3 during colon cancer development.

Authors:  Y Shoji; M Takahashi; T Kitamura; K Watanabe; T Kawamori; T Maruyama; Y Sugimoto; M Negishi; S Narumiya; T Sugimura; K Wakabayashi
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

10.  Regulation of cyclooxygenase-2 (COX-2) expression in human pancreatic carcinoma cells by the insulin-like growth factor-I receptor (IGF-IR) system.

Authors:  Oliver Stoeltzing; Wenbiao Liu; Fan Fan; Christine Wagner; Kathrin Stengel; Ray J Somcio; Niels Reinmuth; Alexander A Parikh; Daniel J Hicklin; Lee M Ellis
Journal:  Cancer Lett       Date:  2007-10-22       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.